Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Very Low Incidence of Clostridioides Difficile Infection in Pediatric Sickle Cell Disease Patients
source: Haematologica
year: 2020
authors: Philip Lee, Arpan A. Sinha, Vijaya L. Soma, Carlos Cruz, Tao Wang, Olga Aroniadis, Betsy C. Herold, Paul S. Frenette, David L. Goldman, and Deepa Manwani
summary/abstract:Despite advances in the survival of pediatric patients with sickle cell disease (SCD), affected individuals continue to experience progressive end-organ damage, recurrent painful vaso-occlusive episodes (VOEs) and a shortened lifespan, highlighting the need for additional therapies. Recent animal and human studies suggest that antibiotic exposure may actually ameliorate the severity of SCD by altering the gastrointestinal microbiome. Specifically, depletion of intestinal microbiota by administration of broad-spectrum antibiotics significantly reduces the number of circulating pro-inflammatory, aged neutrophils and improves inflammation-related organ damage or endotoxin-induced septic shock in mouse models of SCD.
Further, routine administration of penicillin propylaxis to SCD patients up to 5 years of age has also been associated with a reduced percentage and absolute number of aged neutrophils. A recent murine study showed the dependence of stress-induced VOEs and inflammation on the gut microbiota, mediated by aged neutrophil expansion. These observations suggest that in addition to infection prevention, there may be a role for extended antibiotic “prophylaxis” to reduce SCD severity by modulating the gut microbiome to decrease inflammation.
organization: The Children’s Hospital at Montefiore, USA; The University of Oklahoma Health Sciences Center, USA; The Albert Einstein College of Medicine, USA; Montefiore Medical Center, USADOI: 10.3324/haematol.2019.244582
read more
+myBinderRelated Content
-
Practice variation in emergency department management of children with sickle cell disease who present with feverOBJECTIVES:Urgent medical evaluation is ...
-
Does sickle cell disease increase risk of adverse outcomes following total hip and knee arthroplasty? A nationwide d...Sickle cell disease (SCD) is associated ...
-
Safety and early hints of benefit seen in phase 1b trial of PF-04447943Sickle cell disease (SCD) patients were ...
-
Crizanlizumab designated FDA breakthrough therapy for potential in vaso-occlusive crisis preventionCrizanlizumab (SEG101), Novartis‘ inve...
-
Mental Health Resources for Black, Indigenous and People of Color (BIPOC)In addition to COVID-19, recent events h...
-
The Role of Sleep Impairments on Pain Severity in Adults With Sickle Cell DiseaseSleep is a complex process and impairmen...
-
APS Scientific Meeting 2019The American Pain Society will hold its ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.